Amanda Erratt

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study

Alison D. Marshall, Michelle Micallef, Amanda Erratt et al. · International Journal of Drug Policy · 2015 · 61 citations · Full text

Substance Abuse, Hepatology, Alcohol Setting +11

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Jason Grebely, Brian E. Conway, Evan B. Cunningham et al. · International Journal of Drug Policy · 2018 · 32 citations

Viral Hepatitis, Antiviral Drug Development, Hcv Genotype 1 +11

Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study

Andreea Adelina Artenie, Evan B. Cunningham, Gregory J. Dore et al. · Clinical Infectious Diseases · 2019 · 31 citations · Full text

Delivery of treatment for hepatitis C virus infection in the primary care setting

David Baker, Maryam Alavi, Amanda Erratt et al. · European Journal of Gastroenterology & Hepatology · 2014 · 17 citations · Full text